How Can AI Help in the Pharma Industry?

Pharma Tech Outlook: Pharma Tech Magazine

How Can AI Help in the Pharma Industry?

By Pharma Tech Outlook | Friday, December 06, 2019

Expansion in size as well as in medicine datasets is amongst a few factors that have contributed to the development of AI in the pharmaceutical industry.

FREMONT, CA: Artificial Intelligence (AI) is considered to be the growing technology that discovers its application in almost every aspect of life and industry. Similarly, the pharmaceutical industry is introducing innovative methods to make use of persuasive techniques to determine the challenges faced by pharma in the present time. Exploring AI in pharma can include three major divisions, which are innovation, growth, and commercialization. It is significant to remember that AI is best suited to perform recurring tasks wherever there is a lack of efficiency. AI-supported pharmaceutical duties are low at risk, harmless, and lower prices.


Pharmaceutical companies are leveraging AI most in drug discovery as it has nearly no impact on the patients and has lesser risk from that standpoint. Machine learning technology involves a wide range of parameters like genomics, molecular, and cellular structure databases, which are established with it. AI is economical when it comes to predicting potential prospects in drug discovery and is expected to exceed human ability. Additionally, it aids with the identification of many therapies to treat several diseases in a short time.


The drug development techniques require way more of human wisdom, experience, and ability to evolve rapidly. The line of work that helped AI to establish patients individually for clinical trials is shifting into a routine. Acquiring a proper set of patients to enter the clinical trial before the competitors is essential. AI organizations in healthcare are presently offering patient screening and engagement, along with patient identification. Besides that, there are a few pharma companies that have begun to develop their clinical trial AI.


Enormous volumes of knowledge that is required for selling is usually the unstructured data. It causes difficulties for analysis from an associate’s perspective in Nursing AI. Personalization of drugs by AI is a development that has come across for commercial purposes. The wider magnitudes of AI advancement efforts hold precision medicine or predictive medicine, diagnosing, cross-company quality assurance, and radiology applications, client service bots.

See also: Top Pharma and Life Sciences Tech Solution Companies

Weekly Brief

Read Also